Saturday 17 October 2026
Export CCM’s income statement to Excel — free account
Concord Medical Services Holdings Limited
CCM Healthcare Medical Care Facilities
Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.
3.63
0.08
−2.16%
Follow CCM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 3 | 6 | 3 | 4 | 4 | 1 | 4 | 3 | 4 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.11 | 0.15 | 0.32 | 0.55 | 0.82 | 1.97 | 2.03 | 2.26 | 1.63 | 2.18 |
Altman Z-Score |
(1.20) | (1.31) | (1.34) | (1.09) | (0.90) | (0.69) | (0.89) | (0.33) | (0.25) | 0.18 |
Altman Z″-Score (non-manufacturers) |
(3.13) | (3.47) | (3.76) | (2.51) | (2.59) | (1.82) | (2.64) | (0.72) | (0.84) | 0.10 |
P/FCF ratio |
0.25 | 0.35 | 0.75 | 1.18 | 1.30 | 1.78 | 1.74 | 2.32 | 2.24 | 2.99 |
P/Operating CF |
0.21 | 0.30 | 0.64 | 1.01 | 1.11 | 1.52 | 1.49 | 1.98 | 1.91 | 2.55 |
Beneish M-Score |
(5.04) | — | — | — | — | (3.83) | — | (1.86) | (2.98) | (2.71) |
P/B ratio |
0.07 | 0.09 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 2.46 | 0.70 | 0.93 |
Price to Tangible BV |
0.14 | 0.16 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.72 | 0.96 |
EV/Sales |
2.65 | 2.51 | 2.57 | 3.60 | 4.53 | 7.00 | 6.45 | 2.39 | 1.20 | 1.74 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
3.02 | 2.87 | 2.93 | 3.81 | 3.58 | 3.14 | 2.73 | 1.21 | 0.81 | 1.18 |
EV/FCF |
6.10 | 5.79 | 5.92 | 7.70 | 7.23 | 6.34 | 5.52 | 2.45 | 1.64 | 2.39 |
Quick Ratio |
0.18 | 0.20 | 0.08 | 0.26 | 0.36 | 0.86 | 0.29 | 1.14 | 0.73 | 1.01 |
Current Ratio |
0.48 | 0.46 | 0.32 | 0.68 | 0.73 | 1.32 | 0.45 | 1.41 | 1.00 | 1.26 |
Net Debt/EBITDA |
(24.21) | (6.74) | (7.85) | (6.77) | (6.15) | (7.33) | (3.22) | 1.49 | 0.31 | 5.57 |
Debt/Assets |
46.07% | 45.74% | 44.87% | 46.88% | 37.58% | 39.22% | 31.06% | 11.81% | 18.62% | 16.94% |
Debt/Equity |
1.63 | 1.90 | 1.56 | 1.40 | (2.50) | (4.08) | (65.52) | 0.98 | 0.64 | 0.44 |
Asset Turnover |
0.07 | 0.06 | 0.09 | 0.07 | 0.08 | 0.05 | 0.04 | 0.05 | 0.10 | 0.13 |
Operating CF/Net income |
2.17 | 1.29 | 0.93 | 0.44 | 0.44 | 0.34 | 0.35 | 0.11 | (0.09) | 0.30 |
Capex/Depreciation |
(0.33) | (3.14) | (0.91) | (1.64) | (0.82) | (2.19) | (2.91) | (0.95) | (0.52) | (0.53) |
Interest Coverage |
(1.72) | (2.75) | (2.79) | (4.36) | (6.21) | (3.88) | (15.24) | (6.47) | (2.36) | (1.89) |
| (5.46%) | (18.06%) | (15.58%) | (97.79%) | 114.14% | 251.88% | (204.60%) | (44.19%) | (26.21%) | (18.92%) | |
| (1.43%) | (4.76%) | (4.87%) | (7.68%) | (14.35%) | (14.31%) | (12.36%) | (8.71%) | (8.76%) | (7.39%) | |
ROIC |
(3.58%) | (7.69%) | (6.62%) | (7.02%) | (23.05%) | (16.25%) | (22.69%) | (99.09%) | (13.52%) | (10.42%) |
Return on Tangible Assets |
(3.42%) | (12.03%) | (13.45%) | (16.90%) | (28.06%) | (24.60%) | (35.56%) | (22.77%) | (35.69%) | (25.70%) |
Average Days of Receivables |
34.91 | 48.64 | 49.92 | 100.72 | 96.13 | 126.64 | 135.67 | 166.09 | 145.52 | 152.07 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
57.58% | 117.98% | 71.90% | 78.94% | 82.66% | 143.75% | 174.11% | 164.26% | 84.98% | 60.65% |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.15 | 0.15 | 0.20 | 0.14 | 0.17 | 0.14 | 0.00 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | (1.25%) | 3.02% | 9.25% | 10.38% | 5.83% | 3.52% | 1.85% |
Graham Net Nets |
(32.78) | (21.36) | (8.54) | (5.89) | (5.26) | (2.93) | (2.67) | (0.60) | (0.67) | (0.50) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(22.80%) | (16.36%) | (7.65%) | (4.89%) | (3.40%) | (2.52%) | (2.81%) | (20.53%) | (13.95%) | (10.46%) |
Free Cash Flow Yield |
398.02% | 285.57% | 133.60% | 84.42% | 76.82% | 56.07% | 57.54% | 43.16% | 44.66% | 33.47% |
Revenue per Share |
15.08 | 12.04 | 17.33 | 15.67 | 17.44 | 7.82 | 6.56 | 6.40 | 11.73 | 15.05 |
Operating CF per Share |
(6.61) | (12.47) | (8.91) | (7.19) | (12.91) | (8.06) | (6.46) | (1.29) | 0.95 | (2.58) |
Capex per Share |
(1.60) | (12.89) | (3.77) | (7.25) | (3.08) | (6.17) | (5.42) | (1.74) | (1.75) | (2.25) |
Free Cash Flow per Share |
(8.21) | (25.36) | (12.68) | (14.44) | (15.99) | (14.23) | (11.89) | (3.03) | (0.80) | (4.83) |
Cash per Share |
9.78 | 11.66 | 2.92 | 5.29 | 5.80 | 12.77 | 3.62 | 30.40 | 24.14 | 25.39 |
Shareholders Equity per Share |
60.57 | 50.74 | 56.33 | 66.90 | (33.66) | (17.99) | (0.67) | 18.56 | 35.98 | 40.74 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
60.57 | 50.74 | 56.33 | 66.90 | (33.66) | (17.99) | (0.67) | 18.56 | 35.98 | 40.74 |
Free Cash Flow |
(35.85) | (110.77) | (55.41) | (63.08) | (69.84) | (62.18) | (51.61) | (13.16) | (3.48) | (21.03) |
Working Capital |
(144.78) | (156.37) | (187.91) | (52.40) | (34.53) | 25.11 | (49.55) | 52.13 | 0.46 | 35.11 |
Capital Expenditures |
(6.98) | (56.28) | (16.46) | (31.66) | (13.45) | (26.97) | (23.55) | (7.54) | (7.59) | (9.78) |
Net Current Asset Value |
(537.00) | (565.07) | (519.69) | (468.23) | (1,032.94) | (792.55) | (579.64) | (407.70) | (205.85) | (115.51) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.11 | 1.07 | 0.22 | 0.46 | 0.18 | 0.79 | 0.83 | 0.27 | 0.15 | 0.15 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.12 | 0.17 |
Cash ROIC |
(4.85%) | (15.96%) | (8.64%) | (8.72%) | (28.42%) | (20.87%) | (25.23%) | (4.52%) | (0.97%) | (5.73%) |
Accounts Receivable Turnover |
9.90 | 6.06 | 5.18 | 3.51 | 4.77 | 3.04 | 2.45 | 1.69 | 2.14 | 2.15 |
Accounts Payable Turnover |
2.80 | 2.79 | 4.38 | 4.85 | 8.99 | 15.91 | 31.08 | 33.37 | 71.90 | 196.53 |
Inventory Turnover |
11.15 | 12.36 | 9.62 | 9.91 | 18.33 | 16.35 | 55.34 | 34.24 | 39.37 | 56.73 |
Average Days of Payables |
100.16 | 157.15 | 76.83 | 85.77 | 68.97 | 32.40 | 14.11 | 11.60 | 7.15 | 2.61 |
Days of Inventory on Hand |
38.60 | 26.35 | 23.99 | 49.58 | 25.62 | 37.57 | 7.40 | 7.16 | 9.85 | 7.54 |
Average Receivables |
6.65 | 8.68 | 14.62 | 19.48 | 15.96 | 11.22 | 11.61 | 16.46 | 23.79 | 30.50 |
Average Payables |
22.19 | 22.76 | 19.74 | 18.68 | 9.47 | 2.02 | 0.99 | 0.75 | 0.50 | 0.21 |
Average Inventory |
5.58 | 5.13 | 8.99 | 9.14 | 4.64 | 1.97 | 0.56 | 0.73 | 0.91 | 0.73 |
Average Assets |
928.89 | 887.10 | 861.66 | 924.12 | 897.58 | 717.42 | 642.10 | 599.77 | 498.82 | 510.49 |
Average Common Equity |
243.10 | 233.85 | 269.15 | 72.60 | (112.82) | (40.76) | 38.79 | 118.25 | 166.70 | 199.38 |
Columns are period end dates